These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6846967)

  • 1. Progress report on experimental use of CYBEST model 2 for practical gynecologic mass screening. Alterations of the specimen rejection threshold and specimen preparation.
    Mukawa A; Kamitsuma Y; Jisaki F; Tanaka N; Ikeda H; Ueno T; Tsunekawa S
    Anal Quant Cytol; 1983 Mar; 5(1):31-4. PubMed ID: 6846967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field test and experimental use of CYBEST model 2 for practical gynecologic mass screening.
    Tanaka N; Ikeda H; Ueno T; Mukawa A; Kamitsuma K
    Anal Quant Cytol; 1979; 1(2):122-6. PubMed ID: 543573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYBEST model 3 automated cytologic screening system for uterine cancer utilizing image analysis processing.
    Tanaka N; Ueno T; Ikeda H; Ishikawa A; Konoike K; Shimaoka Y; Yamauchi K; Hosoi S; Okamoto Y; Tsunekawa S
    Anal Quant Cytol; 1982 Dec; 4(4):279-85. PubMed ID: 6897700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for gynecologic cancer.
    Pretorius G
    Surg Oncol Clin N Am; 1998 Apr; 7(2):263-9. PubMed ID: 9537975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
    Linder J; Zahniser D
    Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
    Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
    Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamental study of automatic cyto-screening for uterine cancer. III. New system of automated apparatus (CYBEST) utilizing the pattern recognition method.
    Tanaka N; Ikeda H; Ueno T; Watanabe S; Imasato Y
    Acta Cytol; 1977; 21(1):85-9. PubMed ID: 319612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image analysis in cytology: DNA-histogramming versus cervical smear prescreening.
    Bengtsson EW; Nordin B
    Ann Biol Clin (Paris); 1993; 51(1):27-38. PubMed ID: 8338254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
    Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
    Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
    Djemli A; Khetani K; Auger M
    Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the financial impact of covering new screening technologies. The case of automated Pap smears.
    McQuarrie HG; Ogden J; Costa M
    J Reprod Med; 2000 Nov; 45(11):898-906. PubMed ID: 11127101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trials with the cerviscan experimental prescreening device on polylysine-prepared slides.
    Tucker JH; Husain OA
    Anal Quant Cytol; 1981 Jun; 3(2):117-20. PubMed ID: 7020514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New tests for cervical cancer screening.
    Nuovo J; Melnikow J; Howell LP
    Am Fam Physician; 2001 Sep; 64(5):780-6. PubMed ID: 11563569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fundamental study of automatic cyto-screening for uterine cancer. I. Feature evaluation for the pattern recognition system.
    Tanaka N; Ikeda H; Ueno T; Takahashi M; Imasato Y
    Acta Cytol; 1977; 21(1):72-8. PubMed ID: 65093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two cytological methods for screening for cervical cancer].
    Kirschner B; Simonsen K; Junge J
    Ugeskr Laeger; 2008 May; 170(22):1933-7. PubMed ID: 18513478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of PAPNET--a semiautomated system used in the screening against cervical cancer].
    Hølund B; Ejersbo D; Hjortebjerg A
    Ugeskr Laeger; 1998 Sep; 160(40):5802-6. PubMed ID: 9782761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
    Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYBEST-CDMS; automated cell dispersion and monolayer smearing device for CYBEST.
    Tanaka N; Ikeda H; Ueno T; Okamoto Y; Hosoi S
    Anal Quant Cytol; 1981 Jun; 3(2):96-102. PubMed ID: 7258859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semi-automated cervical smear pre-screening systems: an evaluation of the Cytoscan-110.
    Husain OA; Watts KC; Lorriman F; Butler B; Tucker J; Carothers A; Eason P; Farrow S; Rutovitz D; Stark M
    Anal Cell Pathol; 1993 Jan; 5(1):49-68. PubMed ID: 8424901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.